Volume 11 Number 12

Editorial

The Mitral Valve Meeting in Zurich – a world upside down

Serruys PW

10.4244/EIJV11I12A258

free

Oversized post-dilatation of current bioresorbable vascular scaffolds: kill or cure?

von Birgelen C, Basalus M

10.4244/EIJV11I12A259

free

Bioresorbable scaffolds for calcified lesions: not a free lunch!

Capodanno D

10.4244/EIJV11I12A260

free

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) fails to solve the haemodynamic support equation in cardiogenic shock

Kapur N, Zisa D

10.4244/EIJV11I12A2610

free

EAPCI community news

EAPCI Focus on EAPCI Young National Ambassadors

free

Coronary interventions

First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting

Lu H, IJsselmuiden AJ, Grundeken M.J, Nassif M, de Vries A, Weevers A, Scholte M, Spaargaren R, Wykrzykowska JJ, Thijssen J, de Winter R, Koch K

10.4244/EIJY15M05_07

free

Safety and efficacy of lesion preparation with the AngioSculpt Scoring Balloon in left main interventions: the ALSTER Left Main registry

Schmidt T, Hansen S, Meincke F, Frerker C, Kuck K, Bergmann M

10.4244/EIJY15M05_04

free

Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds

Panoulas V, Miyazaki T, Sato K, Naganuma T, Sticchi A, Kawamoto H, Figini F, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A

10.4244/EIJY15M03_11

free

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort

de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H

10.4244/EIJV11I12A265

free

Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial

Kufner S, Byrne RA, Valeskini M, Schulz S, Ibrahim T, Hoppmann P, Schneider S, Laugwitz K, Schunkert H, Kastrati A

10.4244/EIJY14M11_02

free

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions

Lupi A, Rognoni A, Lazzero M, Rolla R, Pergolini P, Bellomo G, Rossi L, Bongo A, Jaffe A

10.4244/EIJY14M11_04

free

Bioabsorbable vascular scaffold overexpansion: insights from in vitro post-expansion experiments

Foin N, Lee R, Mattesini A, Caiazzo G, Fabris E, Kilic D, Chan J, Huang Y, Venkatraman S, Di Mario C, Wong P, Nef H

10.4244/EIJY15M07_02

free

Role of intraprocedural coronary computed tomographic angiography in percutaneous coronary intervention of chronic total occlusion

Kim B, Sumitsuji S, Cho I, Hong M, Kim J, Chang H, Jang Y

10.4244/EIJY15M05_01

free

Interventions for valvular disease and heart failure

Myocardial injury during transfemoral transcatheter aortic valve implantation: an intracoronary Doppler and cardiac magnetic resonance imaging study

Kahlert P, Al-Rashid F, Plicht B, Wild C, Westholter D, Hildebrandt H, Baars T, Neumann T, Nensa F, Nassenstein K, Wendt D, Thielmann M, Jakob H, Kottenberg E, Peters J, Erbel R, Heusch G

10.4244/EIJY15M05_10

free

Video densitometric assessment of aortic regurgitation after transcatheter aortic valve implantation: results from the Brazilian TAVI registry

Tateishi H, Campos C, Abdelghani M, Leite R, Mangione J, Bary L, Soliman O, Spitzer E, Perin M, Onuma Y, Serruys PW, Lemos P, Brito F

10.4244/EIJV11I12A271

free

Evaluation of aortic regurgitation after transcatheter aortic valve implantation: aortic root angiography in comparison to cardiac magnetic resonance

Frick M, Meyer C, Kirschfink A, Altiok E, Lehrke M, Brehmer K, Lotfi S, Hoffmann R

10.4244/EIJY15M03_06

free

Computed tomography optimised fluoroscopy guidance for transcatheter mitral therapies

Van Mieghem NM, Rodriguez-Olivares R, Ben C. Ren B, van Gils L, Maugenest A-M, Geleijnse M, Budde R, Vogelaar J, Verstraeten L, de Jaegere P

10.4244/EIJV11I12A273

free

Transapical valve-in-valve TAVI in a patient with two failing surgical bioprostheses with Edwards SAPIEN 3 valves using a cerebral protection system

Wolf A, Schmitz T, Bigdeli H, Naber CK

10.4244/EIJV11I12A274

free

Preprocedural planning and implantation of a transcatheter aortic valve without the use of contrast agent

Reinöhl J, Pache G, Ahrens I, Heidt T, Psyrakis D, Latib A, De Marco F, Schröfel H, Beyersdorf F, Zehender M, Bode C, von zur Mühlen C

10.4244/EIJY15M07_06

free

How to overcome a scary complication: a mesh-trapped balloon during a CoreValve® implantation procedure

Bayet G, Collet F, Rochas P, Vicat J, Giacomoni M-P, Aymard T

10.4244/EIJY15M06_01

free

Peripheral interventions

Particulates from hydrophilic-coated guiding sheaths embolise to the brain

Stanley J, Tzafriri AR, Regan K, LaRochelle A, Wong G, Zani B, Markham P, Bailey L, Spognardi A, Kopia G, Edelman ER

10.4244/EIJY15M03_02

free

How should I treat?

How should I treat a left ventricular outflow tract-migrated balloon-expandable transcatheter heart valve?

Barbash I, Bogdan A, Fefer P, Spiegelstein D, Raanani E, Beinart R, Guetta V, Segev A

10.4244/EIJV11I12A278

free

Letter to the editor

Recurrent in-stent restenosis: many treatment options, no certainty

Piraino D, Buccheri D, Andolina G

10.4244/EIJV11I12A279

free

Reply to the letter to the editor

Bioresorbable vascular scaffolds for recurrent in-stent restenosis

Rivero F, Benedicto A, Bastante T, García-Guimaraes M, Cuesta J, Alfonso F

10.4244/EIJV11I12A280

free

issue

Volume 11 Number 12

Editorial

EAPCI community news

Coronary interventions

Interventions for valvular disease and heart failure

Peripheral interventions

How should I treat?

Letter to the editor

Reply to the letter to the editor